enVVeno Medical Corporation NVNO
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 29.20% | 31.84% | 11.78% | 10.76% | -3.42% |
| Total Depreciation and Amortization | -23.08% | -22.47% | -3.54% | -7.39% | -8.52% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -50.79% | -47.21% | -11.61% | -8.46% | -0.91% |
| Change in Net Operating Assets | -3,280.00% | -275.16% | 113.98% | -236.55% | 103.61% |
| Cash from Operations | 22.18% | 14.56% | 14.55% | 7.54% | -3.14% |
| Capital Expenditure | 100.00% | 100.00% | 81.48% | 86.49% | 75.68% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2,029.82% | 345.24% | 207.67% | 1,056.05% | 106.45% |
| Cash from Investing | 2,060.84% | 347.76% | 209.47% | 1,087.72% | 106.34% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 354.36% | -91.55% | -92.47% | -92.50% | -99.39% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 354.36% | -91.55% | -92.47% | -92.50% | -99.39% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 106.36% | 337.20% | -154.57% | 170.26% | -226.23% |